These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22811939)

  • 21. Decreased reproducibility and abnormal experience-dependent plasticity of network dynamics in Fragile X circuits.
    Motanis H; Buonomano D
    Sci Rep; 2020 Sep; 10(1):14535. PubMed ID: 32884028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed in vitro development of Up states but normal network plasticity in Fragile X circuits.
    Motanis H; Buonomano D
    Eur J Neurosci; 2015 Sep; 42(6):2312-21. PubMed ID: 26138886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The state of synapses in fragile X syndrome.
    Pfeiffer BE; Huber KM
    Neuroscientist; 2009 Oct; 15(5):549-67. PubMed ID: 19325170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired GABA Neural Circuits Are Critical for Fragile X Syndrome.
    Gao F; Qi L; Yang Z; Yang T; Zhang Y; Xu H; Zhao H
    Neural Plast; 2018; 2018():8423420. PubMed ID: 30402088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragile X mental retardation protein in plasticity and disease.
    Todd PK; Malter JS
    J Neurosci Res; 2002 Dec; 70(5):623-30. PubMed ID: 12424729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The translation of translational control by FMRP: therapeutic targets for FXS.
    Darnell JC; Klann E
    Nat Neurosci; 2013 Nov; 16(11):1530-6. PubMed ID: 23584741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Voltage-Independent SK-Channel Dysfunction Causes Neuronal Hyperexcitability in the Hippocampus of
    Deng PY; Carlin D; Oh YM; Myrick LK; Warren ST; Cavalli V; Klyachko VA
    J Neurosci; 2019 Jan; 39(1):28-43. PubMed ID: 30389838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome.
    Suvrathan A; Hoeffer CA; Wong H; Klann E; Chattarji S
    Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11591-6. PubMed ID: 20534533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
    Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
    Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rescue of NMDAR-dependent synaptic plasticity in Fmr1 knock-out mice.
    Bostrom CA; Majaess NM; Morch K; White E; Eadie BD; Christie BR
    Cereb Cortex; 2015 Jan; 25(1):271-9. PubMed ID: 23968838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered synaptic plasticity in a mouse model of fragile X mental retardation.
    Huber KM; Gallagher SM; Warren ST; Bear MF
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7746-50. PubMed ID: 12032354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
    Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
    Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of activity-mediated spine dynamics and learning impairment in a mouse model of Fragile X syndrome.
    Boda B; Mendez P; Boury-Jamot B; Magara F; Muller D
    Eur J Neurosci; 2014 Apr; 39(7):1130-7. PubMed ID: 24712992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms of fragile X syndrome: a twenty-year perspective.
    Santoro MR; Bray SM; Warren ST
    Annu Rev Pathol; 2012; 7():219-45. PubMed ID: 22017584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
    Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
    PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of ultrasonic vocalizations in a mouse model of fragile X syndrome reveals limited, call type specific deficits.
    Roy S; Watkins N; Heck D
    PLoS One; 2012; 7(9):e44816. PubMed ID: 22984567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early postnatal plasticity in neocortex of Fmr1 knockout mice.
    Desai NS; Casimiro TM; Gruber SM; Vanderklish PW
    J Neurophysiol; 2006 Oct; 96(4):1734-45. PubMed ID: 16823030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal neuronal morphology and neurochemistry in the auditory brainstem of Fmr1 knockout rats.
    Ruby K; Falvey K; Kulesza RJ
    Neuroscience; 2015 Sep; 303():285-98. PubMed ID: 26166728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulation and restoration of homeostatic network plasticity in fragile X syndrome mice.
    Jewett KA; Lee KY; Eagleman DE; Soriano S; Tsai NP
    Neuropharmacology; 2018 Aug; 138():182-192. PubMed ID: 29890190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fragile X Mental Retardation Protein and Dendritic Local Translation of the Alpha Subunit of the Calcium/Calmodulin-Dependent Kinase II Messenger RNA Are Required for the Structural Plasticity Underlying Olfactory Learning.
    Daroles L; Gribaudo S; Doulazmi M; Scotto-Lomassese S; Dubacq C; Mandairon N; Greer CA; Didier A; Trembleau A; Caillé I
    Biol Psychiatry; 2016 Jul; 80(2):149-159. PubMed ID: 26372002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.